Cantor Fitzgerald Weighs in on JANX FY2026 Earnings
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Janux Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings per share of ($4.43) for the year. The consensus […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for Janux Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will post earnings per share of ($4.43) for the year. The consensus […]
